Award Amount:Small Studies: up to $2,500,000; Large Studies: up to $5,000,000 Application Due Date:May 26, 2020
In order to respond to the COVID-19 pandemic, PCORI will issue a new research funding announcement with an accelerated timeline to support innovative, high-impact studies that fit clearly within our core mission of patient-engaged and patient-centered comparative clinical effectiveness research. The objectives of this announcement are to (1) strengthen the understanding of different approaches to mitigate the impact of COVID-19 on individuals, communities, healthcare providers, and healthcare systems; and (2) provide evidence to inform clinical and public health responses, decision making, and planning. PCORI will encourage the use of diverse methods, including interventional studies and the use of natural experiments, to conduct research on an accelerated timeline. Applicants are encouraged to complete primary outcomes collection and provide actionable findings in no longer than 12 months. Hybrid designs, which can provide insight into implementation approaches in the context of evidence generation, will also be welcome. Applicants should be prepared to work independently and/or with PCORI to expedite dissemination of results.